Search research articles
Contact Us
Filters
Showing results (11-20 of 36) with videos related to
Page
of 4
Sort By:
Oncology Research and Treatment
|
March 7, 2023
Durable Response after Olaparib Treatment for Perihilar Cholangiocarcinoma with Germline BRCA2 Mutation
Bruno Almeida Costa, Paulino Tallón de Lara, Wungki Park, et al.
Future Oncology (London, England)
|
November 18, 2022
Tremelimumab and durvalumab in the treatment of unresectable, advanced hepatocellular carcinoma
Tiago Biachi de Castria, Danny N Khalil, James J Harding, et al.
Investigational New Drugs
|
March 10, 2023
A tumor-selective adenoviral vector platform induces transient antiphospholipid antibodies, without increased risk of thrombosis, in phase 1 clinical studies
Danny N Khalil, Isabel Prieto González-Albo, Lee Rosen, et al.
Investigational New Drugs
|
May 11, 2023
Correction to: A tumor-selective adenoviral vector platform induces transient antiphospholipid antibodies, without increased risk of thrombosis, in phase 1 clinical studies
Danny N Khalil, Isabel Prieto González-Albo, Lee Rosen, et al.
Cancers
|
May 14, 2025
Natural Language Processing of Radiology Reports to Assess Survival in Patients with Advanced Melanoma
Jeeban P Das, Jordan Eichholz, Varadan Sevilimedu, et al.
Advances in Cancer Research
|
July 29, 2015
The New Era of Cancer Immunotherapy: Manipulating T-Cell Activity to Overcome Malignancy
Danny N Khalil, Sadna Budhu, Billel Gasmi, et al.
Physics and Imaging in Radiation Oncology
|
November 17, 2022
Stereotactic ablative radiation for pancreatic cancer on a 1.5 Telsa magnetic resonance-linac system
Kathryn R Tringale, Neelam Tyagi, Marsha Reyngold, et al.
International Journal of Molecular Sciences
|
December 9, 2023
Radiation and Immune Checkpoint Inhibitors: Combination Therapy for Treatment of Hepatocellular Carcinoma
Perla Chami, Youssef Diab, Danny N Khalil, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 3, 2016
An Open-Label, Dose-Escalation Phase I Study of Anti-TYRP1 Monoclonal Antibody IMC-20D7S for Patients with Relapsed or Refractory Melanoma
Danny N Khalil, Michael A Postow, Nageatte Ibrahim, et al.
JAMA Oncology
|
April 10, 2025
Nonoperative Management of Technically Resectable Pancreatic Cancer With Ablative Radiation Therapy
Marsha Reyngold, Joshua D Schoenfeld, Eileen M O'Reilly, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 36) with videos related to
Sort By:
Page
of 4
Oncology Research and Treatment
|
March 7, 2023
Durable Response after Olaparib Treatment for Perihilar Cholangiocarcinoma with Germline BRCA2 Mutation
Bruno Almeida Costa, Paulino Tallón de Lara, Wungki Park, et al.
Future Oncology (London, England)
|
November 18, 2022
Tremelimumab and durvalumab in the treatment of unresectable, advanced hepatocellular carcinoma
Tiago Biachi de Castria, Danny N Khalil, James J Harding, et al.
Investigational New Drugs
|
March 10, 2023
A tumor-selective adenoviral vector platform induces transient antiphospholipid antibodies, without increased risk of thrombosis, in phase 1 clinical studies
Danny N Khalil, Isabel Prieto González-Albo, Lee Rosen, et al.
Investigational New Drugs
|
May 11, 2023
Correction to: A tumor-selective adenoviral vector platform induces transient antiphospholipid antibodies, without increased risk of thrombosis, in phase 1 clinical studies
Danny N Khalil, Isabel Prieto González-Albo, Lee Rosen, et al.
Cancers
|
May 14, 2025
Natural Language Processing of Radiology Reports to Assess Survival in Patients with Advanced Melanoma
Jeeban P Das, Jordan Eichholz, Varadan Sevilimedu, et al.
Advances in Cancer Research
|
July 29, 2015
The New Era of Cancer Immunotherapy: Manipulating T-Cell Activity to Overcome Malignancy
Danny N Khalil, Sadna Budhu, Billel Gasmi, et al.
Physics and Imaging in Radiation Oncology
|
November 17, 2022
Stereotactic ablative radiation for pancreatic cancer on a 1.5 Telsa magnetic resonance-linac system
Kathryn R Tringale, Neelam Tyagi, Marsha Reyngold, et al.
International Journal of Molecular Sciences
|
December 9, 2023
Radiation and Immune Checkpoint Inhibitors: Combination Therapy for Treatment of Hepatocellular Carcinoma
Perla Chami, Youssef Diab, Danny N Khalil, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 3, 2016
An Open-Label, Dose-Escalation Phase I Study of Anti-TYRP1 Monoclonal Antibody IMC-20D7S for Patients with Relapsed or Refractory Melanoma
Danny N Khalil, Michael A Postow, Nageatte Ibrahim, et al.
JAMA Oncology
|
April 10, 2025
Nonoperative Management of Technically Resectable Pancreatic Cancer With Ablative Radiation Therapy
Marsha Reyngold, Joshua D Schoenfeld, Eileen M O'Reilly, et al.
Page
of 4